ANTI-TUMOR ACTIVITY, PHARMACOLOGY, AND TOXICITY OF ELLIPTICINES, ELLIPTICINIUM, AND 9-HYDROXY DERIVATIVES - PRELIMINARY CLINICAL-TRIALS OF 2-METHYL-9-HYDROXY ELLIPTICINIUM (NSC 264-137)

被引:0
作者
PAOLETTI, C
LEPECQ, JB
DATXUONG, N
JURET, P
GARNIER, H
AMIEL, JL
ROUESSE, J
机构
来源
RECENT RESULTS IN CANCER RESEARCH | 1980年 / 74卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:107 / 123
页数:17
相关论文
共 47 条
[1]   METHOXY-9-ELLIPTICINE LACTATE IN REFRACTORY ACUTE MYELOID LEUKEMIA [J].
ANSARI, BM ;
THOMPSON, EN .
POSTGRADUATE MEDICAL JOURNAL, 1975, 51 (592) :103-105
[2]   PEROXIDASES-CATALYZED OXIDATION OF THE ANTI-TUMOR DRUG 9-HYDROXY-ELLIPTICINE [J].
AUCLAIR, C ;
GOUYETTE, A ;
PAOLETTI, C .
BIOCHIMIE, 1978, 60 (09) :1073-1074
[3]   NADPH CYTOCHROME-P-450 REDUCTASE ACTIVATION OF QUINONE ANTI-CANCER AGENTS TO FREE-RADICALS [J].
BACHUR, NR ;
GORDON, SL ;
GEE, MV ;
KON, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (02) :954-957
[4]  
BACHUR NR, 1978, CANCER RES, V38, P1745
[5]  
BRANFMAN AR, 1978, DRUG METAB DISPOS, V6, P542
[6]  
BRUGAROLAS A, 1979, CANCER RES, V20, pC77
[7]  
CHADWICK M, 1978, DRUG METAB DISPOS, V6, P528
[8]  
CROS J, 1975, CR ACAD SCI D NAT, V281, P1139
[9]   SYNTHESIS OF TUMOUR-INHIBITORY ALKALOIDS ELLIPTICINE 9-METHOXYELLIPTICINE AND RELATED PYRIDO[4,3-B]CARBAZOLES [J].
DALTON, LK ;
DEMERAC, S ;
ELMES, BC ;
LODER, JW ;
SWAN, JM ;
TEITEI, T .
AUSTRALIAN JOURNAL OF CHEMISTRY, 1967, 20 (12) :2715-&
[10]  
DUFER J, 1973, ANN PHARM FR, V31, P441